StockWatch
·

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q1 FY26 Results

SPARCQ1 FY26 Results
Filing
MetricValue (₹ Cr)vs Q4 FY25
Revenue9.6464.5%
Total Income18.7830.9%
Expenditure70.5919.7%
PBT-51.8114.6%
Net Profit-51.8713.2%
OPM—
NPM—
EPS1.6013.0%
View full financials

Informational and educational content only. Not investment advice.